PNTG · Pennant Group, Inc. · Insider Trading

$39.00 -1.50 (-3.70%) At close · Sep 30

Russell 2000 member Rebalance outlook locked

Market Cap

$1.42B

34.93M

Volume · Sep 30 248.73K Avg daily vol (3M) 317.01K

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

-2

Net shares bought

-0.02%

Net buy value

-$218,727

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-08-06	Steik Jason Paul	Chief Clinical Officer	Sell↓	Common Stock	1,394	$38.52	$53,700	15,106
2026-08-06	Guerisoli Brent	Chief Executive Officer	Sell↓ Filing footnotes — Common Stock (Direct) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024	Common Stock	4,285	$38.52	$165,067	99,544
2026-08-06	Cheney Kirk Sterling	EVP, GC and Corp Secy	Sell↓ Filing footnotes — Common Stock (Direct) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 26, 2022	Common Stock	1,393	$38.52	$53,661	18,401
2026-07-15	Nackel John G.	Insider	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning July 15, 2027.	Common Stock	1,900	—	—	174,565
2026-07-15	Lamb Scott E	Chief Financial Officer,	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning July 15, 2027.	Common Stock	2,400	—	—	58,935
2026-07-15	Morris Gregory K Sr.	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning July 15, 2027.	Common Stock	1,900	—	—	37,300
2026-07-15	Christensen Christopher R.	Director, Executive Chairman	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning July 15, 2027.	Common Stock	1,900	—	—	145,991
2026-07-15	SMITH BARRY M	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning July 15, 2027.	Common Stock	1,900	—	—	102,499
2026-07-15	Snapper Suzanne D.	Director, CFO	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning July 15, 2027.	Common Stock	1,900	—	—	230,364
2026-07-15	COVEY STEPHEN M R	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning July 15, 2027.	Common Stock	1,900	—	—	44,050
2026-07-10	Guerisoli Brent	Chief Executive Officer	Convert↑	Common Stock	6,248	$4.54	$28,366	106,988
2026-07-10	Guerisoli Brent	Chief Executive Officer	Sell↓	Common Stock	3,159	$41.57	$131,304	103,829
2026-07-10	Guerisoli Brent	Chief Executive Officer	Convert↓	Stock Option (right to buy)	6,248	$4.54	$28,366	0
2026-07-07	Guerisoli Brent	Chief Executive Officer	Sell↓	Common Stock	3,165	$40.51	$128,214	100,740
2026-07-07	Guerisoli Brent	Chief Executive Officer	Convert↑	Common Stock	6,249	$4.54	$28,370	103,905
2026-07-07	Guerisoli Brent	Chief Executive Officer	Convert↓	Stock Option (right to buy)	6,249	$4.54	$28,370	6,248
2026-05-22	Guerisoli Brent	Chief Executive Officer	Convert↑	Common Stock	4,463	$3.84	$17,138	99,910
2026-05-22	Guerisoli Brent	Chief Executive Officer	Sell↓	Common Stock	2,254	$35.08	$79,070	97,656
2026-05-22	Guerisoli Brent	Chief Executive Officer	Convert↑	Common Stock	4,463	$3.84	$17,138	97,701
2026-05-22	Guerisoli Brent	Chief Executive Officer	Sell↓ Filing footnotes — Common Stock (Direct) This transaction was executed in multiple trades at price of $35.10. The reporting person hereby undertakes to provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares executed at each separate price.	Common Stock	200	$35.10	$7,020	95,447
2026-05-22	Guerisoli Brent	Chief Executive Officer	Sell↓ Filing footnotes — Common Stock (Direct) This transaction was executed in multiple trades at price of $35.08. The reporting person hereby undertakes to provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares executed at each separate price.	Common Stock	2,032	$35.08	$71,283	95,647
2026-05-22	Guerisoli Brent	Chief Executive Officer	Sell↓	Common Stock	22	$34.86	$767	97,679
2026-05-22	Guerisoli Brent	Chief Executive Officer	Convert↓	Stock Option (right to buy)	4,463	$3.84	$17,138	0
2026-05-22	Guerisoli Brent	Chief Executive Officer	Convert↓	Stock Option (right to buy)	4,463	$3.84	$17,138	4,463
2026-04-15	SMITH BARRY M	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning April 15, 2027.	Common Stock	1,900	—	—	100,599
2026-04-15	Nackel John G.	Insider	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning April 15, 2027.	Common Stock	1,900	—	—	172,665
2026-04-15	COVEY STEPHEN M R	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning April 15, 2027.	Common Stock	1,900	—	—	42,150
2026-04-15	Morris Gregory K Sr.	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning April 15, 2027.	Common Stock	1,900	—	—	35,400
2026-04-15	Christensen Christopher R.	Director, Executive Chairman	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning April 15, 2027.	Common Stock	1,900	—	—	144,091
2026-04-15	Snapper Suzanne D.	Director, CFO	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning April 15, 2027.	Common Stock	1,900	—	—	228,464
2026-04-15	Lamb Scott E	Chief Financial Officer,	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning April 15, 2027.	Common Stock	2,400	—	—	56,535
2026-03-05	Cheney Kirk Sterling	EVP, GC and Corp Secy	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) These shares vest in five equal annual installments beginning March 5, 2027.	Stock Option (right to buy)	30,000	$33.30	$999,000	30,000
2026-03-05	Guerisoli Brent	Chief Executive Officer	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) These shares vest in five equal annual installments beginning March 5, 2027.	Stock Option (right to buy)	45,000	$33.30	$1,498,500	45,000
2026-03-05	Walbom Lynette	Chief Financial Officer	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) These shares vest in five equal annual installments beginning March 5, 2027.	Stock Option (right to buy)	34,000	$33.30	$1,132,200	34,000
2026-03-05	Gochnour John J	Chief Operating Officer	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) These shares vest in five equal annual installments beginning March 5, 2027.	Stock Option (right to buy)	41,000	$33.30	$1,365,300	41,000
2026-03-05	Steik Jason Paul	Chief Clinical Officer	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) These shares vest in five equal annual installments beginning March 5, 2027.	Stock Option (right to buy)	26,000	$33.30	$865,800	26,000
2026-03-03	Guerisoli Brent	Chief Executive Officer	Award↑ Filing footnotes — Common Stock (Direct) These shares vest immediately on March 3, 2026. This amendment is being filed to correct the amount of securities beneficially owned as of the transaction date reported above.	Common Stock	11,260	—	—	93,238
2026-03-03	Cheney Kirk Sterling	EVP, GC and Corp Secy	Award↑ Filing footnotes — Common Stock (Direct) These shares vest immediately on March 3, 2026. This amendment is being filed to correct the amount of securities beneficially owned as of the transaction date reported above.	Common Stock	2,874	—	—	19,794
2026-03-03	Walbom Lynette	Chief Financial Officer	Award↑ Filing footnotes — Common Stock (Direct) These shares vest immediately on March 3, 2026. This amendment is being filed to correct the amount of securities beneficially owned as of the transaction date reported above.	Common Stock	8,025	—	—	10,688
2026-03-03	Gochnour John J	Chief Operating Officer	Award↑ Filing footnotes — Common Stock (Direct) These shares vest immediately on March 3, 2026. This amendment is being filed to correct the amount of securities beneficially owned as of the transaction date reported above.	Common Stock	11,214	—	—	145,464
2026-01-15	Nackel John G.	Insider	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning January 15, 2027.	Common Stock	1,900	—	—	170,765
2026-01-15	Lamb Scott E	Chief Financial Officer,	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning January 15, 2027.	Common Stock	2,400	—	—	54,135
2026-01-15	Morris Gregory K Sr.	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning January 15, 2027.	Common Stock	1,900	—	—	33,500
2026-01-15	SMITH BARRY M	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning January 15, 2027.	Common Stock	1,900	—	—	98,699
2026-01-15	Christensen Christopher R.	Director, Executive Chairman	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning January 15, 2027.	Common Stock	1,900	—	—	142,191
2026-01-15	Snapper Suzanne D.	Director, CFO	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning January 15, 2027.	Common Stock	1,900	—	—	226,564
2026-01-15	COVEY STEPHEN M R	Director	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning January 15, 2027.	Common Stock	1,900	—	—	40,250
2025-11-11	Cheney Kirk Sterling	EVP, GC and Corp Secy	Convert↓ Filing footnotes — Stock Option (right to buy) (Direct) Represents the exercise of an employee option that fully vested in 2024, first became exercisable on October 1, 2020, and expires on October 1, 2029 (to the extent not previously exercised).	Stock Option (right to buy)	3,800	—	—	4,200
2025-11-11	Cheney Kirk Sterling	EVP, GC and Corp Secy	Convert↑	Common Stock	3,800	$15.09	$57,342	16,920
2025-10-15	Christensen Christopher R.	Director, Executive Chairman	Award↑ Filing footnotes — Common Stock (Direct) These shares vest in three annual installments beginning October 15, 2026.	Common Stock	1,900	—	—	140,291

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 366 transactions

Key facts CIK 1766400 CUSIP 70805E109 13F (30d) 6 filings 6 filers Visit website Investor relations